MNT To Support Weight Loss: Optimising Semaglutide Therapy Growing scientific evidence supports the use of MNT to improve both the tolerability and the efficacy of semaglutide, thereby optimising clinical outcomes in obesity management [96,97,98,99,100,101,102,103,104,105,106,107]
Information about data access request proposals can be found at Change history 28 May 2024 In the version of the article initially published, in Fig
Although patients with type 2 diabetes are a patient group in which the risk of major congenital malformations is higher than the general population, these studies present the first results on the risk of major congenital malformation after periconceptional GLP-1 RA exposure in women (Dolk et al
These factors determine the brain's capacity for learning and memory at the most fundamental level